RESEARCH-USE BIOSIMILAR ANTIBODY
Bapotulimab
Monoclonal antibody · IgG2
Bapotulimab (BAY-1905254) is a fully human IgG2 antibody targeting immunoglobulin-like domain containing receptor 2 (ILDR2). Bapotulimab has antitumor and immunosuppressive effects.
TARGETILDR2
YMonoclonal antibody
CATALOGSC-BS-745
CATALOG NUMBERSC-BS-745
MOLECULAR WEIGHTApprox. 144.98 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Bapotulimab (BAY-1905254) is a fully human IgG2 antibody targeting immunoglobulin-like domain containing receptor 2 (ILDR2). Bapotulimab has antitumor and immunosuppressive effects.
Bapotulimab is a recombinant research-use antibody directed against ILDR2.